171 related articles for article (PubMed ID: 36211430)
1. Outcome of SARS-CoV-2 infection among patients with common variable immunodeficiency and a matched control group: A Danish nationwide cohort study.
Katzenstein TL; Rasmussen LD; Drabe CH; Larsen CS; Hansen AE; Stærkind M; Knudsen LS; Hansen CH; Obel N
Front Immunol; 2022; 13():994253. PubMed ID: 36211430
[TBL] [Abstract][Full Text] [Related]
2. Low morbidity in Danish patients with common variable immunodeficiency disorder infected with severe acute respiratory syndrome coronavirus 2.
Drabe CH; Hansen AE; Rasmussen LD; Larsen OD; Møller A; Mogensen TH; Helweg-Larsen J; Katzenstein TL
Infect Dis (Lond); 2021; 53(12):953-958. PubMed ID: 34375571
[TBL] [Abstract][Full Text] [Related]
3. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity.
van Leeuwen LPM; GeurtsvanKessel CH; Ellerbroek PM; de Bree GJ; Potjewijd J; Rutgers A; Jolink H; van de Veerdonk F; van Gorp ECM; de Wilt F; Bogers S; Gommers L; Geers D; Bruns AHW; Leavis HL; van Haga JW; Lemkes BA; van der Veen A; de Kruijf-Bazen SFJ; van Paassen P; de Leeuw K; van de Ven AAJM; Verbeek-Menken PH; van Wengen A; Arend SM; Ruten-Budde AJ; van der Ent MW; van Hagen PM; Sanders RW; Grobben M; van der Straten K; Burger JA; Poniman M; Nierkens S; van Gils MJ; de Vries RD; Dalm VASH
J Allergy Clin Immunol; 2022 Jun; 149(6):1949-1957. PubMed ID: 35421449
[TBL] [Abstract][Full Text] [Related]
5. Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity.
van Leeuwen LPM; Grobben M; GeurtsvanKessel CH; Ellerbroek PM; de Bree GJ; Potjewijd J; Rutgers A; Jolink H; van de Veerdonk FL; van Gils MJ; de Vries RD; Dalm VASH;
J Clin Immunol; 2023 Aug; 43(6):1104-1117. PubMed ID: 37231290
[TBL] [Abstract][Full Text] [Related]
6. The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency.
Quinti I; Locatelli F; Carsetti R
Front Immunol; 2021; 12():815404. PubMed ID: 35126372
[TBL] [Abstract][Full Text] [Related]
7. Outcomes following SARS-CoV-2 infection in individuals with and without solid organ transplantation-A Danish nationwide cohort study.
Overvad M; Koch A; Jespersen B; Gustafsson F; Krause TG; Hansen CH; Ethelberg S; Obel N
Am J Transplant; 2022 Nov; 22(11):2627-2636. PubMed ID: 35801493
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy.
Antolí A; Rocamora-Blanch G; Framil M; Mas-Bosch V; Navarro S; Bermudez C; Martinez-Yelamos S; Dopico E; Calatayud L; Garcia-Muñoz N; Hernández-Benítez LH; Riera-Mestre A; Bas J; Masuet-Aumatell C; Rigo-Bonnin R; Morandeira F; Solanich X
Front Immunol; 2022; 13():895209. PubMed ID: 35572562
[TBL] [Abstract][Full Text] [Related]
9. The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet).
Giardino G; Milito C; Lougaris V; Punziano A; Carrabba M; Cinetto F; Scarpa R; Dellepiane RM; Ricci S; Rivalta B; Conti F; Marzollo A; Firinu D; Cirillo E; Lagnese G; Cancrini C; Martire B; Danieli MG; Pession A; Vacca A; Azzari C; Fabio G; Soresina A; Agostini C; Spadaro G; Badolato R; Cicalese MP; Aiuti A; Plebani A; Quinti I; Pignata C
J Clin Immunol; 2022 Jul; 42(5):935-946. PubMed ID: 35445287
[TBL] [Abstract][Full Text] [Related]
10. Outcomes following SARS-CoV-2 infection in individuals with and without inflammatory rheumatic diseases: a Danish nationwide cohort study.
Svensson ALL; Emborg HD; Bartels LE; Ellingsen T; Adelsten T; Cordtz R; Dreyer L; Obel N
Ann Rheum Dis; 2023 Oct; 82(10):1359-1367. PubMed ID: 37414519
[TBL] [Abstract][Full Text] [Related]
11. Outcomes following severe acute respiratory syndrome coronavirus 2 infection among individuals with and without HIV in Denmark.
Rasmussen LD; Cowan S; Gerstoft J; Kronborg G; Johansen IS; Larsen CS; Weise L; Dalager-Pedersen M; Leth S; Nielsen LN; Lunding S; Omland LH; Obel N
AIDS; 2023 Feb; 37(2):311-321. PubMed ID: 36129108
[TBL] [Abstract][Full Text] [Related]
12. Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.
Gram MA; Nielsen J; Schelde AB; Nielsen KF; Moustsen-Helms IR; Sørensen AKB; Valentiner-Branth P; Emborg HD
PLoS Med; 2021 Dec; 18(12):e1003874. PubMed ID: 34919548
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Infection and Risk of Postacute Psychiatric and Neurologic Diagnoses: A Nationwide Danish Cohort Study.
Nielsen NM; Spiliopoulos L; Hansen JV; Videbech P; Hviid A
Neurology; 2024 Mar; 102(5):e208113. PubMed ID: 38382013
[TBL] [Abstract][Full Text] [Related]
14. Specific Antibody and the T-Cell Response Elicited by BNT162b2 Boosting After Two ChAdOx1 nCoV-19 in Common Variable Immunodeficiency.
Goda V; Kriván G; Kulcsár A; Gönczi M; Tasnády S; Matula Z; Nagy G; Bekő G; Horváth M; Uher F; Szekanecz Z; Vályi-Nagy I
Front Immunol; 2022; 13():907125. PubMed ID: 35784359
[TBL] [Abstract][Full Text] [Related]
15. Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden.
Nordström P; Ballin M; Nordström A
Lancet Infect Dis; 2022 Jun; 22(6):781-790. PubMed ID: 35366962
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency.
Arroyo-Sánchez D; Cabrera-Marante O; Laguna-Goya R; Almendro-Vázquez P; Carretero O; Gil-Etayo FJ; Suàrez-Fernández P; Pérez-Romero P; Rodríguez de Frías E; Serrano A; Allende LM; Pleguezuelo D; Paz-Artal E
J Clin Immunol; 2022 Feb; 42(2):240-252. PubMed ID: 34787773
[TBL] [Abstract][Full Text] [Related]
17. HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients.
Steiner S; Sotzny F; Bauer S; Na IK; Schmueck-Henneresse M; Corman VM; Schwarz T; Drosten C; Wendering DJ; Behrends U; Volk HD; Scheibenbogen C; Hanitsch LG
Front Immunol; 2020; 11():607918. PubMed ID: 33424856
[TBL] [Abstract][Full Text] [Related]
18. Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19.
Ameratunga R; Longhurst H; Steele R; Lehnert K; Leung E; Brooks AES; Woon ST
J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3575-3583. PubMed ID: 34182162
[TBL] [Abstract][Full Text] [Related]
19. Functionally impaired antibody response to BNT162b2 booster vaccination in CVID IgG responders.
Sauerwein KMT; Geier CB; Stemberger RF; Rossmanith R; Akyaman H; Illes P; Fischer MB; Eibl MM; Walter JE; Wolf HM
J Allergy Clin Immunol; 2023 Apr; 151(4):922-925. PubMed ID: 36463978
[TBL] [Abstract][Full Text] [Related]
20. High Prevalence of Long COVID in Common Variable Immunodeficiency: An Italian Multicentric Study.
Villa A; Milito C; Deiana CM; Gambier RF; Punziano A; Buso H; Bez P; Lagnese G; Garzi G; Costanzo G; Giannuzzi G; Pagnozzi C; Dalm VASH; Spadaro G; Rattazzi M; Cinetto F; Firinu D
J Clin Immunol; 2024 Feb; 44(2):59. PubMed ID: 38319477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
